期刊文献+

冠状动脉粥样硬化患者血清Klotho与糖脂代谢紊乱的相关性研究 被引量:13

Association between serum Klotho and metabolic disorders of glucose/lipids in patients with coronary atherosclerosis
原文传递
导出
摘要 目的:探讨冠状动脉粥样硬化患者血清Klotho水平与糖脂代谢紊乱的相关性。方法:采用横断面研究的方法,连续纳入2017年12月-2018年4月于我院心内科经冠状动脉造影确诊的308例冠状动脉粥样硬化患者,收集患者病史信息、实验室指标及冠状动脉造影数据,采用酶联免疫吸附试验检测血清Klotho水平。按血清Klotho中位数将研究人群分为低值组(≤296.8 pg/ml)和高值组(>296.8 pg/ml),并比较两组间的临床资料。采用Spearman秩相关、ROC曲线、Logistic回归模型评估Klotho水平与糖脂代谢紊乱的相关性。结果:Klotho低值组脂质异常、糖代谢紊乱(GMD)和代谢综合征(MetS)的发生率显著高于高值组(P<0.001);Klotho水平与糖脂代谢指标显著负相关(P<0.05);脂质异常、GMD和MetS患者的Klotho水平较对照组显著降低(P<0.001)。ROC曲线显示,Klotho对脂质异常、GMD和MetS具有较好的诊断效能,其曲线下面积分别为0.731、0.728和0.713(P<0.001)。多因素Logistic回归分析进一步表明,Klotho与MetS独立显著相关(OR=0.991,95%CI:0.988~0.994,P<0.001),高水平Klotho可能是MetS的保护性因素(OR=0.181,95%CI:0.101~0.327,P<0.001)。结论:血清Klotho与糖脂代谢紊乱相关,低水平Klotho可能是MetS的独立危险因素。 Objective:To investigate the association of serum Klotho with metabolic disorders of glucose/lipids in patients with coronary atherosclerosis.Method:This was a cross-sectional study involving 308 patients diagnosed with coronary atherosclerosis by coronary angiography who were admitted between December 2017 and April 2018 in our hospital.The data about medical history,laboratory parameters,and coronary angiography were obtained from medical records.Serum Klotho was detected by Enzyme linked immunosorbent assay.According to Klotho median,the subjects were divided into the low Klotho group(≤296.8 pg/ml)and the high Klotho group(>296.8 pg/ml),and clinical data between the two groups were compared.Spearman rank correlation analysis,ROC curve analysis,and Logistic regression models were performed to evaluate the association of Klotho with metabolic disorders of glucose and lipids.Result:The low Klotho group had higher incidences of dyslipidemia,glucose metabolism disorders(GMD),and metabolic syndrome(MetS)(P<0.001).Serum Klotho was significantly negatively correlated with metabolic indicators(P<0.05)Serum Klotho levels in patients with dyslipidemia,GMD,or MetS were significantly lower than those in the control group(P<0.001).ROC curve analyses showed that Klotho had good diagnostic performances for dyslipidemia,GMDs and MetS;the area under the curve was 0.731,0.728 and 0.713,respectively(P<0.001).Multivariate Logistic regression analysis further indicated that Klotho was significantly associated with MetS independently(OR=0.991,95%CI:0.988—0.994,P<0.001);high Klotho might be a protective factor for MetS(OR=0.181,95%CI:0.101—0.327,P<0.001).Conclusion:Serum Klotho is associated with metabolic disorders of glucose and lipids;and low Klotho may be an independent risk factor for MetS.
作者 毛琦 项朝君 童武阳 赵晓辉 MAO Qi;XIANG Chaojun;TONG Wuyang;ZHAO Xiaohui(Department of Cardiology,Institute of Cardiovascular Research,Second Affiliated Hospital of Army Medical University,Chongqing,400037,China)
出处 《临床心血管病杂志》 CAS 北大核心 2020年第3期238-243,共6页 Journal of Clinical Cardiology
基金 国家自然科学基金面上项目(No:81670428).
关键词 KLOTHO 动脉粥样硬化 脂质异常 代谢综合征 Klotho atherosclerosis dyslipidemia metabolic syndrome
  • 相关文献

参考文献3

二级参考文献24

  • 1廖玉华,杨杰孚,张健,程翔,谢明星,李新立,董吁钢,周京敏,伍伟锋,郭小梅,无.舒张性心力衰竭诊断和治疗专家共识[J].临床心血管病杂志,2020,36(1):1-10. 被引量:120
  • 2张坚,满青青,王春荣,李红,由悦,翟屹,李莹,赵文华.中国18岁及以上人群血脂水平及分布特征[J].中华预防医学杂志,2005,39(5):302-305. 被引量:112
  • 3VANDVIK P O, LINEOFF A M, GORE J M, et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis,9th ed : American College of Chest Physi- cians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141: e637S--e668S.
  • 4HALVORSEN S, ANDREOTTI F, TEN BERG J M, et al. Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis [J]. J Am Coll Cardiol, 2014, 64: 319--327.
  • 5CAPRIE STEERING COMMITTEE. A randomised,blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J]. Lancet, 1996, 348, 1329--1339.
  • 6SEREBRUANY V L, MALININ A I, EISERT R M, et al. Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials FJ]. Am J Hematol, 2004, 75: 40--47.
  • 7DAMMANN H G, BURKHARDT F, WOLF N. Enteric coating of aspirin significantly decreases gas- troduodenal mucosal lesions [J]. Aliment Pharmacol Ther, 1999, 13: 1109--1114.
  • 8YUSUF S, ZHAO F, MEHTA S R, et al. Effects of clopidogrel in addition to aspirin in patients with a- cute coronary syndromes without ST-segment eleva- tion [J]. N Engl J Med, 2001, S45: 494--502.
  • 9DIENER H C, BOGOUSSLAVSKY J, BRASS L M, et al. Aspirin and clopidogrel compared with clopi- dogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patient (MATCH) : ran- domized, double-blind, placebo-controlled trial [J]. Lancet, 2004, 364: 331--337.
  • 10BHATT D L, FOX K A, HACKE W, et al. Clopi- dogrel and aspirin versus aspirin alone for the preven- tion of atherothrombotic events [J]. N Engl J Med, 2006, 354.. 1706--1717.

共引文献2141

同被引文献142

引证文献13

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部